Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto: Schedule Product: Creon 10000. Active Ingredient: Pancreatin 150 mg. Dosage Form: Modified release capsule. NZ Sponsor: Boehringer Ingelheim (NZ) Limited. Manufacturer(s): Solvay Pharmaceuticals GmbH, Neustadt a.Rdge, Germany. Product: Micardis. Active Ingredient: Telmisartan 40 mg. Dosage Form: Tablet. NZ Sponsor: Boehringer Ingelheim (NZ) Limited. Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany. Product: Micardis. Active Ingredient: Telmisartan 80 mg. Dosage Form: Tablet. NZ Sponsor: Boehringer Ingelheim (NZ) Limited. Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany. Product: Pritor. Active Ingredient: Telmisartan 40 mg. Dosage Form: Tablet. NZ Sponsor: Glaxo Wellcome New Zealand Limited. Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany. Product: Pritor. Active Ingredient: Telmisartan 80 mg. Dosage Form: Tablet. NZ Sponsor: Glaxo Wellcome New Zealand Limited. Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany. Product: Sandostatin LAR. Active Ingredient: Octreotide acetate 11.2 mg. Dosage Form: Powder for injection. NZ Sponsor: Novartis New Zealand Limited. Manufacturer(s): Novartis Pharma AG, (Manufacturing site), Basel, Switzerland. Product: Sandostatin LAR. Active Ingredient: Octreotide acetate 22.4 mg. Dosage Form: Powder for injection. NZ Sponsor: Novartis New Zealand Limited. Manufacturer(s): Novartis Pharma AG, (Manufacturing site), Basel, Switzerland. Product: Sandostatin LAR. Active Ingredient: Octreotide acetate 33.6 mg. Dosage Form: Powder for injection. NZ Sponsor: Novartis New Zealand Limited. Manufacturer(s): Novartis Pharma AG, (Manufacturing site), Basel, Switzerland. Product: Solu-Medrol Act-O-Vial. Active Ingredient: Methylprednisolone sodium succinate 728.67 mg equivalent to 500 mg of free base in 4 ml. Dosage Form: Injection with diluent. NZ Sponsor: Pharmacia & Upjohn. Manufacturer(s): Pharmacia & Upjohn Company, Kalamazoo, Michigan, U.S.A. Pharmacia & Upjohn NV/SA, Puurs, Belgium. Dated this 13th day of September 1999. G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).